市场调查报告书
商品编码
1433456
全球多毛症治疗市场 2023-2030Global Hirsutism Treatment Market 2023-2030 |
预计在预测期内(2024-2031),全球多毛症治疗市场将以 7.2% 的CAGR成长。该市场的成长归因于女性多毛症的日益普及。据美国家庭医师学会称,多毛症影响着约 8.0% 的女性,据估计,美国每年的经济负担超过 6 亿美元。与多余毛髮相关的美容和心理问题以及多囊性卵巢综合症的日益流行是预计在预测期内推动市场成长的主要因素。此外,传统的除毛方法,如穿线、打蜡、拔毛和漂白,由于其优越的长期效果,已在很大程度上被雷射除毛所取代。根据 2022 年 6 月发表在《临床与美容皮肤病学杂誌》上的一篇文章,据观察,由于雷射技术的发展,雷射现在已成为去除多余毛髮的首选方法。因此,技术的不断改进和人们越来越多地采用雷射治疗预计将在预测期内推动多毛症治疗的成长。
全球多毛症治疗市场按治疗类型、应用和最终用途细分。根据治疗类型,市场分为药物和手术。根据应用,市场细分为上唇、下巴、胸部、手臂等。其他包括颈部和下背部。此外,根据最终用途,市场细分为医院、皮肤科诊所和美容中心。在最终用途中,皮肤科诊所和美容中心细分市场预计将在预测期内占据最大的市场份额。该细分市场的大部分份额归功于更低的成本、更高的效率和可用性。
人们对外表的日益关注以及皮肤护理支出的增加导致了该细分市场的成长。女性脸部毛髮的体积和类型各不相同。根据 Clinique Matrice 发表的文章,女性下颚线和上唇外角有浅色脸部毛髮的情况很常见。这种天然的脸部毛髮被称为桃绒毛。来自欧洲国家(包括义大利和希腊)和印度次内容的女性往往比世界其他地区的女性有更多的脸部毛髮。
全球多毛症治疗市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本) 、韩国和亚洲其他地区),以及世界其他地区(中东和非洲以及拉丁美洲)。其中,亚太地区预计在预测期内以最高的CAGR增长。多毛症治疗、老年人口的增加、个人护理支出的增加以及除毛治疗的增加推动了亚太地区多毛症治疗市场的发展。
预计在预测期内,北美将在多毛症治疗市场中占据显着份额。影响区域市场份额的重要因素包括多毛症病例数量的增加、生活方式的改变以及消费者消费能力的增强。根据 NIH 的数据,多毛症是最常见的内分泌疾病,影响近 10.0% 的美国女性。儘管有根本原因,多毛症仍有可能导致严重的情绪困扰和心理困扰。此外,治疗多毛症的诊所数量不断增加,也促进了该地区的市场成长。 2020 年 2 月,医学院网站管理员、接受过内分泌学进修训练的内科助理教授 Su Hee Kim 博士在中年健康中心开设了一个新的 PCOS 诊所。该诊所为患有代谢问题、与 PCOS 相关的多毛症的女性,特别是需要减肥医疗帮助的 PCOS 女性提供护理。
服务多毛症治疗市场的主要公司包括 Alma Lasers Ltd、Cynosure Inc.、Lumenis Inc.、Nisim Inc. 等。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布),为市场成长做出了巨大贡献,以保持市场竞争力。例如,2022 年 10 月,Endymed Ltd. 获得 FDA 批准在美国行销和销售新型除毛设备 Pure Laser。此次推出帮助公司改善了向公司合作伙伴和客户提供的美学产品的多样性。
Global Hirsutism Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Medications, and Procedures), By Application, (Upper Lip, Chin, Chest, Arms, Others), by End-use (Hospitals, Dermatology Clinics, and Aesthetic Centers), Forecast Period (2024-2031)
The global hirsutism treatment market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period (2024-2031). The growth of this market is attributed to the increasing prevalence of hirsutism among women. According to the American Academy of Family Physicians, hirsutism affects around 8.0% of women, and it is associated with an estimated economic burden surpassing $600 million annually in the US. Cosmetic and psychological problems associated with unwanted hair and the increasing prevalence of polycystic ovary syndrome are major factors projected to fuel market growth during the forecast period. Further, traditional hair removal methods such as threading, waxing, plucking, and bleaching have largely been replaced by laser hair removal owing to their superior long-term results. According to an article published in the Journal of Clinical and Aesthetic Dermatology in June 2022, it has been observed that lasers are now the preferred method for getting rid of unwanted hair because of developments in laser technology. Thus, continuous improvements in technology and increasing adoption of laser treatments among the population are anticipated to propel the growth of hirsutism treatment during the forecast period.
The global hirsutism treatment market is segmented by treatment type, application, and end-use. Based on the treatment type, the market is sub-segmented into medications and procedures. Based on the application, the market is sub-segmented into upper lip, chin, chest, arms, and others. Where others include the neck and lower back. Further, based on end-use, the market is sub-segmented into hospitals, dermatology clinics, and aesthetic centers. Among the end-use, the dermatology clinics, and aesthetic centers sub-segment is anticipated to hold the largest market share during the forecast period. The large share of this segment is credited to lower costs, higher efficiency, and availability.
The rising concerns about appearance among individuals, and rising expenditure on skin care, attributing to the segmental growth. Facial hair varies in volume and type in women. As per the article published by Clinique Matrice, it is common for women to have light facial hair on the exterior corners of the jawline and upper lip. This natural facial hair is beneficial termed peach fuzz. Women from European countries (including Italy and Greece) and the Indian sub-content tend to have extra facial hair than women in other parts of the world.
The global hirsutism treatment market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to grow at the highest CAGR over the forecast period. The growing demand for hirsutism treatment, the increasing geriatric population, the rising personal care expenditure, and increasing treatment for hair removal treatment driving the hirsutism treatment market in the Asia-Pacific.
North America is expected to hold a prominent share in the Hirsutism Treatment market during the forecast period. The significant factors contributing to the regional market share include the increasing number of hirsutism cases, changing lifestyles, and the increased spending power of consumers. According to the NIH, hirsutism is the most common endocrine disorder affecting nearly 10.0% of women in the US. Despite the underlying cause, hirsutism has the potential to cause significant emotional distress and psychological distress. Additionally, the increasing number of clinics for the treatment of hirsutism boosts the market growth in the region. In February 2020, the School of Medicine Webmaster, Dr. Su Hee Kim, Assistant Professor in Internal Medicine with fellowship training in Endocrinology, started a new PCOS clinic at the Midlife Health Center. This clinic offered care for women with metabolic issues, hirsutism related to PCOS, and especially women with PCOS requiring medical help with weight loss.
The major companies serving the hirsutism treatment market include Alma Lasers Ltd, Cynosure Inc., Lumenis Inc., Nisim Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2022, Endymed Ltd. received FDA approval for the marketing and sales of Pure Laser, a new hair removal device in the US. This launch helped the company to improve the variety of its aesthetic offerings to both the Company's partners and clients.